CLINICAL TRIALS PROFILE FOR HYZAAR
✉ Email this page to a colleague
All Clinical Trials for HYZAAR
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00234858 ↗ | Tarka vs. Hyzaar in Patients With Metabolic Syndrome (STAR) | Completed | Abbott | Phase 4 | 2004-03-01 | The primary objective of this study is to determine whether impaired glucose tolerance is improved to a greater degree by Tarka than Hyzaar in subjects with metabolic syndrome |
| NCT00274638 ↗ | PROBE Parallel 6-week Treatment Comparing Telmisartan/Hydrochlorothiazide (HCT) (40/12.5 or 80/12.5) With Losartan/HCT (50/12.5) Using Ambulatory Blood Pressure Monitoring (ABPM) | Completed | Boehringer Ingelheim | Phase 4 | 2002-07-01 | To demonstrate that Telmisartan combined with Hydrochlorothiazide (MICARDIS® HCT) is superior to Losartan with Hydrochlorothiazide (Hyzaar®) in lowering blood pressure in mild-moderate hypertensives. |
| NCT00354991 ↗ | Hyzaar Asia HEAALTH (0954A-950) | Completed | Merck Sharp & Dohme Corp. | Phase 3 | 2006-06-01 | The objective of the study is to estimate the percentage of patients who reach blood pressure goal after 8 weeks of treatment with losartan/HCTZ combination. |
| NCT00398541 ↗ | Evaluation of the Antihypertensive Effect of Hyzaar(R) and Cognitive Function of Hypertensive Patients (0954A-322) | Completed | Merck Sharp & Dohme Corp. | Phase 3 | 2005-03-01 | Evaluate the antihypertensive and neuroprotective effects of Hyzaar(R) in elderly subjects in comparison with Natrilix(TM). |
| NCT00400218 ↗ | Evaluate the Safety and Anti-Hypertensive Efficacy of Hyzaar(R) In Patients With Mild To Moderate Essential Hypertension (0954A-323) | Completed | Merck Sharp & Dohme Corp. | Phase 3 | 2005-09-01 | Evaluate the safety and anti-hypertensive efficacy of hyzaar(R) in patients with mild to moderate essential hypertension. |
| NCT00480805 ↗ | HYZAAR vs. Ramipril for Diabetes (0954A-245)(COMPLETED) | Completed | Merck Sharp & Dohme Corp. | Phase 3 | 2001-08-08 | A study to test the safety and efficacy of HYZAAR as compared to Ramipril in patients with type 2 diabetes mellitus (high blood sugar) and hypertension (high blood pressure). |
| NCT01149473 ↗ | Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Non-Fasting Conditions | Completed | Teva Pharmaceuticals USA | Phase 1 | 2004-03-01 | The objective of this study is to compare the relative bioavailability of Losartan potassium/Hydrochlorothiazide 100/25 mg tablets (manufactured by Teva Pharmaceutical Industries, Ltd. and distributed by Teva Pharmaceuticals USA) with that of Hyzaar® 100/25 mg tablets (Merck) in healthy, adult, non-smoking subjects under non-fasting conditions. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for HYZAAR
Condition Name
Clinical Trial Locations for HYZAAR
Trials by Country
Clinical Trial Progress for HYZAAR
Clinical Trial Phase
Clinical Trial Sponsors for HYZAAR
Sponsor Name
